Literature DB >> 24306778

Structural investigation of protonated azidothymidine and protonated dimer.

Blake E Ziegler1, Rick A Marta, Michael B Burt, Sabrina M Martens, Jonathan K Martens, Terry B McMahon.   

Abstract

Infrared multiple photon dissociation (IRMPD) spectroscopy experiments and quantum chemical calculations have been used to explore the possible structures of protonated azidothymidine and the corresponding protonated dimer. Many interesting differences between the protonated and neutral forms of azidothymidine were found, particularly associated with keto-enol tautomerization. Comparison of computational vibrational and the experimental IMRPD spectra show good agreement and give confidence that the dominant protonated species has been identified. The protonated dimer of azidothymidine exhibits three intramolecular hydrogen bonds. The IRMPD spectrum of the protonated dimer is consistent with the spectrum of the most stable computational structure. This work brings to light interesting keto-enol tautomerization and exocyclic hydrogen bonding involving azidothymidine and its protonated dimer. The fact that one dominant protonated species is observed in the gas phase, despite both the keto and enol structures being similar in energy, is proposed to be the direct result of the electrospray ionization process in which the dominant protonated dimer structure dissociates in the most energetically favorable way.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24306778     DOI: 10.1007/s13361-013-0767-x

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  37 in total

1.  Proton affinity of uracil. A computational study of protonation sites.

Authors:  J K Wolken; F Ture ek
Journal:  J Am Soc Mass Spectrom       Date:  2000-12       Impact factor: 3.109

Review 2.  HIV-1 protease: mechanism and drug discovery.

Authors:  Ashraf Brik; Chi-Huey Wong
Journal:  Org Biomol Chem       Date:  2003-01-07       Impact factor: 3.876

3.  Chirality-induced conformational preferences in peptide-metal ion binding revealed by IR spectroscopy.

Authors:  Robert C Dunbar; Jeffrey D Steill; Jos Oomens
Journal:  J Am Chem Soc       Date:  2010-12-30       Impact factor: 15.419

4.  Computational Thermochemistry: Scale Factor Databases and Scale Factors for Vibrational Frequencies Obtained from Electronic Model Chemistries.

Authors:  I M Alecu; Jingjing Zheng; Yan Zhao; Donald G Truhlar
Journal:  J Chem Theory Comput       Date:  2010-08-20       Impact factor: 6.006

5.  Tridentate ionic hydrogen-bonding interactions of the 5-fluorocytosine cationic dimer and other 5-fluorocytosine analogues characterized by IRMPD spectroscopy and electronic structure calculations.

Authors:  Sabrina M Martens; Rick A Marta; Jonathan K Martens; Terry B McMahon
Journal:  J Phys Chem A       Date:  2011-08-10       Impact factor: 2.781

Review 6.  In search of a treatment for HIV--current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs).

Authors:  Chevonne Reynolds; Charles B de Koning; Stephen C Pelly; Willem A L van Otterlo; Moira L Bode
Journal:  Chem Soc Rev       Date:  2012-05-22       Impact factor: 54.564

7.  Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus.

Authors:  W Ostertag; G Roesler; C J Krieg; J Kind; T Cole; T Crozier; G Gaedicke; G Steinheider; N Kluge; S Dube
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

8.  AZT (zidovudine) just a step away from FDA approval for AIDS therapy.

Authors:  C Marwick
Journal:  JAMA       Date:  1987-03-13       Impact factor: 56.272

9.  An investigation of protonation sites and conformations of protonated amino acids by IRMPD spectroscopy.

Authors:  Ronghu Wu; Terry B McMahon
Journal:  Chemphyschem       Date:  2008-12-22       Impact factor: 3.102

Review 10.  Reflections on 30 years of AIDS.

Authors:  Kevin M De Cock; Harold W Jaffe; James W Curran
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.